Acetaminophen administration and the risk of acute kidney injury: a self-controlled case series study
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Acetaminophen (APAP) is frequently used for analgesia and is considered safer than nonsteroidal anti-inflammatory drugs (NSAIDs) for the kidneys. However, there is little epidemiological evidence of the association between APAP and acute kidney injury (AKI). OBJECTIVES: To examine the association between APAP and AKI using the self-controlled case series (SCCS) method, which is a novel strategy to control between-person confounders by comparing the risk and reference periods in each patient. METHODS: We performed SCCS in 1,871 patients (39.9% female) who were administered APAP and subsequently developed AKI, by reviewing electronically stored hospital information system data from May 2011 to July 2016. We used conditional Poisson regression to compare each patient's risk and reference period. As a time-varying confounder, we adjusted the status of liver and kidney functions, systemic inflammation, and exposure to NSAIDs. RESULTS: We identified 5,650 AKI events during the 260,549 person-day observation period. The unadjusted incidences during the reference and exposure periods were 2.01/100 and 3.12/100 person-days, respectively. The incidence rate ratio adjusted with SCCS was 1.03 (95% confidence interval [CI]: 0.95-1.12). When we restricted endpoints as stage 2 AKI- and stage 3 AKI-level creatinine elevations, the incidence rate ratios were 1.20 (95% CI 0.91-1.58) and 1.20 (95% CI 0.62-2.31), respectively, neither of which was statistically significant. CONCLUSION: Our findings added epidemiological information for the relationship between APAP administration and AKI development. The results indicated scarce association between APAP and AKI, presumably supporting the general physicians' impression that APAP is safer for kidney.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“On the contrary, therapeutic doses of paracetamol are generally safe and do not lead to acute renal failure in patients with renal impairment.89”
From An Updated Review on the Metabolite (AM404)-Mediated Central Mechanism of Action of Paracetamol (Acetaminophen): Experimental Evidence and Potential Clinical Impact (2023) · cites this paper as [89]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Differential Diagnosis of Glomerular Disease: A Systematic and Inclusive Approach
Hebert, L. A., Parikh, S., Prosek, J., Nadasdy, T., & Rovin, B. H. (2013) · American Journal of Nephrology · doi:10.1159/000354390 · Cited by 4,376
Chou, R., Qaseem, A., Snow, V., Casey, D., Cross, J. T., Shekelle, P., Owens, D. K., & for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians and the American College of Physicians/American Pain Society Low Back Pain Guidelines Panel* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00006 · Cited by 2,718 · cited 1×
“8 Although there is quite limited epidemiological evidence for the association between therapeutic-dose APAP and AKI, guidelines, 9,10 textbook, 11 and even the National Kidney Foundation web page 12 describes its safer profile for the kidney, which is widely known among physicians.”
Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes
Chawla, L. S., Eggers, P. W., Star, R. A., & Kimmel, P. L. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1214243 · Cited by 1,977 · cited 1×
“24,25 9-12 Therefore, kidney function is also a time-varying confounder to be adjusted.”
Danan, G., & Benichou, C. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90101-6 · Cited by 1,481 · cited 1×
“22 We assumed liver function impairment to be transient and to occur independently of the kidney injury.”
Chapter 1: Definition and classification of CKD
(2013) · Kidney International Supplements · doi:10.1038/kisup.2012.64 · Cited by 1,110
Mechanisms of Acetaminophen-Induced Liver Necrosis
Hinson, J. A., Roberts, D. W., & James, L. P. (2010) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-00663-0_12 · Cited by 1,006
A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis
Cooper, B. A., Branley, P., Bulfone, L., Collins, J. F., Craig, J. C., Fraenkel, M. B., Harris, A., Johnson, D. W., Kesselhut, J., Li, J. J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000552 · Cited by 854 · cited 1×
“73 m(2) can be seen as end-stage renal disease (ESRD) patients.(19) The inclusion flow diagram is shown in Figure 2.”
Chronic Dialysis and Death Among Survivors of Acute Kidney Injury Requiring Dialysis
Wald, R. (2009) · JAMA · doi:10.1001/jama.2009.1322 · Cited by 780 · cited 1×
“AKI can sometimes be a lethal condition, 45 and it is also well known that those who recovered from AKI can progress to chronic kidney disease, 46 which is a major risk factor for cardiovascular diseases.”
Tutorial in biostatistics: the self‐controlled case series method
Whitaker, H. J., Paddy Farrington, C., Spiessens, B., & Musonda, P. (2006) · Statistics in Medicine · doi:10.1002/sim.2302 · Cited by 719 · cited 2×
“SCCS is a kind of case-series method developed recently.(15,16) The method compares incident rates during time periods with different risk statuses within each individual in order to estimate the incident rate ratio of risk factors.”
Acute Kidney Injury and Mortality in Hospitalized Patients
Wang, H. E., Muntner, P., Chertow, G. M., & Warnock, D. G. (2012) · American Journal of Nephrology · doi:10.1159/000337487 · Cited by 540 · cited 1×
“7% of hospitalized patients, especially those in a severely ill condition.(29,30) Clinically ill conditions are generally transient and such patients tend to need APAP as analgesic agents, hence, the general condition of the patient is a time-variable confounder.”
Self controlled case series methods: an alternative to standard epidemiological study designs
Petersen, I., Douglas, I., & Whitaker, H. (2016) · BMJ · doi:10.1136/bmj.i4515 · Cited by 525
A SIMPLE METHOD OF ESTIMATING PROGRESSION OF CHRONIC RENAL FAILURE
Mitch, W. E., Walser, M., Buffington, G. A., & Lemann, J. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91974-7 · Cited by 459
Högestätt, E. D., Jönsson, B. A. G., Ermund, A., Andersson, D. A., Björk, H., Alexander, J. P., Cravatt, B. F., Basbaum, A. I., & Zygmunt, P. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501489200 · Cited by 454
Paracetamol Overdosage Pharmacological Considerations and Clinical Management
Prescott, L. F. (1983) · Drugs · doi:10.2165/00003495-198325030-00002 · Cited by 425
Perlman, R. L., Finkelstein, F. O., Liu, L., Roys, E., Kiser, M., Eisele, G., Burrows-Hudson, S., Messana, J. M., Levin, N., Rajagopalan, S., et al. (2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2004.12.021 · Cited by 410
Acetaminophen-induced nephrotoxicity: Pathophysiology, clinical manifestations, and management
Mazer, M., & Perrone, J. (2008) · Journal of Medical Toxicology · doi:10.1007/bf03160941 · Cited by 396
Relative Incidence Estimation from Case Series for Vaccine Safety Evaluation
Farrington, C. P. (1995) · Biometrics · doi:10.2307/2533328 · Cited by 367
Mechanism of Action of Acetaminophen: Is There a Cyclooxygenase 3?
Botting, R. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317520 · Cited by 350
Drug-induced nephrotoxicity: concluded
(1984) · Reactions · doi:10.1007/bf03273412 · Cited by 339
Nonsteroidal Antiinflammatory Drugs and Acute Renal Failure in Elderly Persons
Griffin, M. R., Yared, A., & Ray, W. A. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010234 · Cited by 271
Summary of Recommendation Statements
(2012) · Kidney International Supplements · doi:10.1038/kisup.2012.7 · Cited by 260
James, M. T., Ghali, W. A., Tonelli, M., Faris, P., Knudtson, M. L., Pannu, N., Klarenbach, S. W., Manns, B. J., & Hemmelgarn, B. R. (2010) · Kidney International · doi:10.1038/ki.2010.258 · Cited by 246 · cited 1×
“AKI can lower patients’ quality of life, 47,48 and therefore, prevention of AKI is very important.”
Drug-induced impairment of renal function
Shirali, A., & Pazhayattil, G. S. (2014) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s39747 · Cited by 227
Hubbard, R. (2003) · American Journal of Epidemiology · doi:10.1093/aje/kwg114 · Cited by 197 · cited 1×
“43 One study investigated the association between antidepressants and hip fracture using both SCCS and conventional case–control method and concluded that SCCS could perform more accurately than case–control methods, 44 indicating that SCCS is potentially valuable for our research purposes.”
COX-3 and the mechanism of action of paracetamol/acetaminophen
Botting, R., & Ayoub, S. S. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.10.005 · Cited by 180 · cited 1×
“35 Several researchers have indicated that cyclooxygenase-3 might be a target enzyme of APAP, 36,37 while other in vivo data have suggested that another metabolite, named AM404, was the key factor in the mechanism of APAP as an analgesic agent.”
Cartin-Ceba, R., Kashiouris, M., Plataki, M., Kor, D. J., Gajic, O., & Casey, E. T. (2012) · Critical Care Research and Practice · doi:10.1155/2012/691013 · Cited by 179
Henrich, W. L., Agodoa, L. E., Barrett, B., Bennett, W. M., Blantz, R. C., Buckalew, V. M., D'Agati, V. D., DeBroe, M. E., Duggin, G. G., Eknoyan, G., et al. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90046-3 · Cited by 178
Risk of Stroke Following Herpes Zoster: A Self-Controlled Case-Series Study
Langan, S. M., Minassian, C., Smeeth, L., & Thomas, S. L. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu098 · Cited by 163 · cited 1×
“17 SCCS can therefore avoid time-independent confounding factors occurring between study subjects by comparing “risk” and “reference” periods within individuals; thus, there is no need for a separate control group.”
Long-term functional evolution after an acute kidney injury: a 10-year study
Ponte, B., Felipe, C., Muriel, A., Tenorio, M. T., & Liaño, F. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn398 · Cited by 148 · cited 1×
“AKI can sometimes be a lethal condition, 45 and it is also well known that those who recovered from AKI can progress to chronic kidney disease, 46 which is a major risk factor for cardiovascular diseases.”
Acetaminophen hepatoxicity: What do we know, what don’t we know, and what do we do next?†
Kaplowitz, N. (2004) · Hepatology · doi:10.1002/hep.20312 · Cited by 142 · cited 1×
“Although there is quite limited epidemiological evidence for the association between therapeutic-dose APAP and AKI, guidelines,(9,10) textbook,(11) and even the National Kidney Foundation web page(12) describes its safer profile for the kidney, which is widely known among physicians.(13) In contrast, an official medic…”
Generalized nonlinear models in R: An overview of the gnm package
Turner, H., & Firth, D. (2007) · Cited by 139
2017 update on pain management in patients with chronic kidney disease
Pham, P. C., Khaing, K., Sievers, T. M., Pham, P. M., Miller, J. M., Pham, S. V., Pham, P. A., & Pham, P. T. T. (2017) · Clinical Kidney Journal · doi:10.1093/ckj/sfx080 · Cited by 137 · cited 1×
“8 Although there is quite limited epidemiological evidence for the association between therapeutic-dose APAP and AKI, guidelines, 9,10 textbook, 11 and even the National Kidney Foundation web page 12 describes its safer profile for the kidney, which is widely known among physicians.”
Acute renal failure due to acetaminophen ingestion: a case report and review of the literature.
Blakely, P., & McDonald, B. R. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v6148 · Cited by 135
WELDESELASSIE, Y. G., WHITAKER, H. J., & FARRINGTON, C. P. (2011) · Epidemiology and Infection · doi:10.1017/s0950268811001531 · Cited by 130 · cited 1×
“41 Recently, researchers have investigated the associations between drug administration and some events by this method using existing electronically stored databases, with examples including antipsychotic drugs and myocardial infarction 42 and thiazolidinediones and fracture.”
Biomarkers of Acute Kidney Injury: An Evolving Domain
McIlroy, D. R., Wagener, G., Lee, H. T., & Riou, B. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181cded3f · Cited by 113 · cited 1×
“Washout period Serum creatinine, which is the key value defining AKI, is reported to elevate 24 and 48 h after kidney damage.(21) In addition, little is known about the lead time between APAP administration and the onset of kidney injury.”
The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study
Douglas, I. J., Evans, S. J., Pocock, S., & Smeeth, L. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000154 · Cited by 112 · cited 1×
“43 One study investigated the association between antidepressants and hip fracture using both SCCS and conventional case–control method and concluded that SCCS could perform more accurately than case–control methods, 44 indicating that SCCS is potentially valuable for our research purposes.”
Acetaminophen-induced hepatotoxicity: Preventive effect of trans anethole
da Rocha, B. A., Ritter, A. M. V., Ames, F. Q., Gonçalves, O. H., Leimann, F. V., Bracht, L., Natali, M. R. M., Cuman, R. K. N., & Bersani‐Amado, C. A. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.014 · Cited by 50
Antipsychotic drugs and risks of myocardial infarction: a self-controlled case series study
Brauer, R., Smeeth, L., Anaya-Izquierdo, K., Timmis, A., Denaxas, S. C., Farrington, C. P., Whitaker, H., Hemingway, H., & Douglas, I. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehu263 · Cited by 42 · cited 1×
“41 Recently, researchers have investigated the associations between drug administration and some events by this method using existing electronically stored databases, with examples including antipsychotic drugs and myocardial infarction 42 and thiazolidinediones and fracture.”
Risk of Acute Kidney Injury and Long-Term Outcome in Patients With Acetaminophen Intoxication
Chen, Y., Lin, C., Dai, M., Chang, P., Chen, J.-H., Huang, T., Wu, Y., & Kao, C. (2015) · Medicine · doi:10.1097/md.0000000000002040 · Cited by 36
Incidence and characterization of acute kidney injury after acetaminophen overdose
Stollings, J. L., Wheeler, A. P., & Rice, T. W. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.06.004 · Cited by 33 · cited 2×
“Previous case reports 2-4 and cohort studies 5,6 have suggested an association between supratherapeutic doses of APAP and AKI.”
Dual role of acetaminophen in promoting hepatoma cell apoptosis and kidney fibroblast proliferation
Yu, Y., Yiang, G., Chou, P. L., Tseng, H.-H., Wu, T. K., Hung, Y.-T., LIN, P.-S., LIN, S.-Y., LIU, H.-C., CHANG, W.-J., et al. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2085 · Cited by 32 · cited 1×
“8 Although there is quite limited epidemiological evidence for the association between therapeutic-dose APAP and AKI, guidelines, 9,10 textbook, 11 and even the National Kidney Foundation web page 12 describes its safer profile for the kidney, which is widely known among physicians.”
Chand, D. H., & Patwardhan, M. B. (2019) · Springer eBooks · doi:10.1007/978-981-13-2276-1_18 · Cited by 31
Kato, H., Fujigaki, Y., Inoue, R., Asakawa, S., Shin, S., Shima, T., 古西純子, Higaki, M., Tanemoto, M., Yamaguchi, Y., et al. (2014) · Internal Medicine · doi:10.2169/internalmedicine.53.1502 · Cited by 22 · cited 2×
“7 Looking at in vitro data, APAP in therapeutic doses is said to induce fibroblast proliferation, possibly resulting in kidney injury, but its clinical implications have not yet been proven.”
Kelkar, M., Cleves, M. A., Foster, H. R., Hogan, W. R., James, L. P., & Martin, B. C. (2012) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2012.18.3.234 · Cited by 22
Loh, C., & Ponampalam, R. (2006) · Hong Kong Journal of Emergency Medicine · doi:10.1177/102490790601300202 · Cited by 14
Park, K. M. (2014) · Kidney Research and Clinical Practice · doi:10.1016/j.krcp.2014.04.005 · Cited by 4 · cited 1×
“Kidney function impairment Kidney function declines gradually over time,(23) and impaired kidney function is revealed to be the risk factor of AKI development.(24,25) In addition, patients with impaired kidney function are more likely to be prescribed APAP,(26) adhering to the recommendation of guidelines(27) and othe…”
Cited by
Mallet, C., Desmeules, J., Pegahi, R., & Eschalier, A. (2023) · Journal of Pain Research · doi:10.2147/jpr.s393809 · Cited by 83
“On the contrary, therapeutic doses of paracetamol are generally safe and do not lead to acute renal failure in patients with renal impairment.(89) It was previously hypothesized that paracetamol may cause renal injury due to the reports of nephropathy after phenacetin overuse; however, this hypothesis was then rejecte…”
BackgroundAlchin, J., Dhar, A., Siddiqui, K., & Christo, P. J. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2049551 · Cited by 65
Toxicological Property of Acetaminophen: The Dark Side of a Safe Antipyretic/Analgesic Drug?
Ishitsuka, Y., Kondo, Y., & Kadowaki, D. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b19-00722 · Cited by 63
Ding, Y., Zhong, R., Jiang, R., Yang, X., He, L., Yuan, L., & Cheng, D. (2023) · ACS Sensors · doi:10.1021/acssensors.2c02610 · Cited by 46
Roles of Hydrogen Sulfide Donors in Common Kidney Diseases
Ngowi, E. E., Sarfraz, M., Afzal, A., Khan, N. H., Khattak, S., Zhang, X., Li, T., Duan, S., Ji, X., & Wu, D. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.564281 · Cited by 50
“APAP/paracetamol-induced nephrotoxicity is amongst the least causatives of renal injury (Hiragi et al., 2018).”
Background
Metadata
- Authors
- Hiragi, S., Yamada, H., Tsukomoto, T., Yoshida, K., Kondo, N., Matsubara, T., Yanagita, M., Tamura, H., & Kuroda, T.
- Affiliations
- Kyoto University (JP)
- Harvard University (US)
- Kyoto University Hospital (JP)
- Corresponding author
- Hiragi, Shusuke
- ORCID
- Venue
- Clinical Epidemiology
- Publisher
- Informa UK Limited
- Published
- 2018-03
- Volume
- Volume 10
- Pages
- 265-276
- ISSN
- 1179-1349 (ISSN-L)
- PMC
- PMC5846761
- OpenAlex
- W2793234939
- Cited by
- 35
- References
- 47
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 5 · 2022: 7 · 2021: 2 · 2020: 6 · 2019: 7
- FWCI
- 3.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Clinical Epidemiology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion)
- Funders
- Japan Society for the Promotion of Science (16K12523)
- Topics
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Nephrotoxicity and Medicinal Plants
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- paracetamol, acute kidney injury, drug safety, nonsteroidal anti-inflammatory drugs, self-controlled case series, time-varying confounding, creatinine elevation, analgesia, renal function
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.